Westgeest Annette C, Hanssen Jaap L J, de Boer Mark G J, Schippers Emile F, Lambregts Merel M C
Department of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands.
Department of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands.
Clin Microbiol Infect. 2025 Feb;31(2):173-181. doi: 10.1016/j.cmi.2024.01.003. Epub 2024 Jan 11.
Methicillin-resistant Staphylococcus aureus (MRSA) colonization increases infection risk in both patients and healthy individuals. Decolonization therapy has been proven to reduce S. aureus infections, but data on the effectiveness of individual decolonization strategies in community-onset MRSA carriage are scarce.
The aim of this narrative review was to summarize the evidence on strategies for the elimination of MRSA colonization in community-onset MRSA carriers.
PubMed database was searched for studies on MRSA eradication, from inception to July 2023.
Topical therapy is proven to be effective in nasal-only carriage and in temporary load reduction. Mupirocin nasal ointment in combination with chlorhexidine body wash is highly effective in nasal-only MRSA carriers in the community as well. In patients with extra-nasal colonization, addition of orally administered antibiotics likely increases success rates compared with topical therapy alone. Studies on systemic treatment of extra-nasal MRSA decolonization are subject to a high heterogeneity of antimicrobial agents, treatment duration, and control groups. The majority of evidence supports the use of a combination of topical therapy with rifampin and another antimicrobial agent. Decolonization treatment with probiotics is a promising novel non-antibiotic strategy. However, achieving long-term decolonization is more likely in countries with low MRSA prevalence, given the risk of recolonization in a context of high MRSA prevalence.
The decision to pursue community-onset MRSA eradication treatment in the individual patient should be based on the combination of the treatment objective (short-term bacterial load reduction in health care settings vs. long-term eradication in community settings), and the likelihood of successful decolonization. The latter is influenced by both individual risk factors for treatment failure, and the risk of recolonization. The addition of a combination of systemic antibiotics is rational for extra-nasal long-term decolonization. To determine the most effective systemic antimicrobial agents in MRSA decolonization, more research is needed.
耐甲氧西林金黄色葡萄球菌(MRSA)定植会增加患者和健康个体的感染风险。去定植治疗已被证明可减少金黄色葡萄球菌感染,但关于个体去定植策略对社区获得性MRSA携带有效性的数据却很稀少。
本叙述性综述的目的是总结关于消除社区获得性MRSA携带者中MRSA定植策略的证据。
检索PubMed数据库中从开始到2023年7月关于MRSA根除的研究。
局部治疗已被证明对单纯鼻腔携带和临时降低菌量有效。莫匹罗星鼻软膏联合洗必泰沐浴露对社区中单纯鼻腔MRSA携带者也非常有效。对于有鼻外定植的患者,与单独局部治疗相比,加用口服抗生素可能会提高成功率。关于鼻外MRSA去定植的全身治疗研究在抗菌药物、治疗持续时间和对照组方面存在高度异质性。大多数证据支持使用局部治疗联合利福平及另一种抗菌药物。用益生菌进行去定植治疗是一种有前景的新型非抗生素策略。然而,鉴于在MRSA高流行情况下存在再定植风险,在MRSA患病率低的国家更有可能实现长期去定植。
对于个体患者是否进行社区获得性MRSA根除治疗的决定应基于治疗目标(在医疗环境中短期降低细菌载量与在社区环境中长期根除)以及去定植成功的可能性。后者受治疗失败的个体风险因素和再定植风险的影响。加用全身抗生素联合治疗对于鼻外长期去定植是合理的。为了确定MRSA去定植中最有效的全身抗菌药物,还需要更多研究。